Oncology and Hematology

17-32 of 612

Recognizing High-Risk Profiles for NSCLC
Recognizing High-Risk Profiles for NSCLC
Project Oncology®
Recognizing High-Risk Profiles for NSCLC
- Jobelle Baldonado, MD
Oncogenic Drivers in Never-Smokers with NSCLC
Oncogenic Drivers in Never-Smokers with NSCLC
Project Oncology®
Oncogenic Drivers in Never-Smokers with NSCLC
- Apar Kishor Ganti, MD, MS
Expanding Molecular Testing in Community NSCLC Care
Expanding Molecular Testing in Community NSCLC Care
Project Oncology®
Expanding Molecular Testing in Community NSCLC Care
- Apar Kishor Ganti, MD, MS
Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
Project Oncology®
Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
- Brian P. McDonough, MD, FAAFP
- Tara Graff, DO, MS
- Surbhi Sidana, MD
Tracking Treatment Response: ctDNA Insights in MMR-p Colon Cancer
Tracking Treatment Response: ctDNA Insights in MMR-p Colon Cancer
Project Oncology®
Tracking Treatment Response: ctDNA Insights in MMR-p Colon Cancer
- Brian P. McDonough, MD, FAAFP
- Christopher T. Chen, MD
Addressing Unmet Needs in First-Line mTNBC Care
Addressing Unmet Needs in First-Line mTNBC Care
On the Frontlines of Metastatic Breast Cancer
Addressing Unmet Needs in First-Line mTNBC Care
- Jennifer Caudle, DO, FACOFP
- Alexis Ann LeVee, MD
Optimizing Care for Older Adults With FLT3-Mutated AML
Optimizing Care for Older Adults With FLT3-Mutated AML
Global Oncology Academy
Optimizing Care for Older Adults With FLT3-Mutated AML
- Ryan Quigley
- Nicholas Short, MD
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
- Maxwell Llyod, MD
- Ryan Quigley
Modern Management of ROS1-Positive Non-Small Cell Lung Cancer
Modern Management of ROS1-Positive Non-Small Cell Lung Cancer
Project Oncology®
Modern Management of ROS1-Positive Non-Small Cell Lung Cancer
Understanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Cancer
Understanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Cancer
AudioAbstracts
Understanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Cancer
- Ryan Quigley
Bridging Gaps with Blood-Based CRC Screening
Bridging Gaps with Blood-Based CRC Screening
On the Frontlines of Colorectal Cancer
Bridging Gaps with Blood-Based CRC Screening
- Ryan Quigley
- Aasma Shaukat, MD, MPH
Evolving Strategies in CRC Care: Screening, Treatment, and Equity
Evolving Strategies in CRC Care: Screening, Treatment, and Equity
On the Frontlines of Colorectal Cancer
Evolving Strategies in CRC Care: Screening, Treatment, and Equity
- Ryan Quigley
- Thomas Cataldo, MD
- Sowmya Sharma, MD
Prioritizing Quality of Life in CRC: Key Surgical Considerations
Prioritizing Quality of Life in CRC: Key Surgical Considerations
On the Frontlines of Colorectal Cancer
Prioritizing Quality of Life in CRC: Key Surgical Considerations
- Ryan Quigley
- Thomas Cataldo, MD
- Sowmya Sharma, MD
How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
Project Oncology®
How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
- Jennifer Caudle, DO, FACOFP
- Mansi R. Shah, MD
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
CME/CE
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
0.25 credits
- Charles E. Geyer Jr., MD, FACP
- Komal Jhaveri, MD, FACP
0.25 credits
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
Project Oncology®
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
- Ryan Quigley